15. November 2018, Datwyler sees attractive growth potential in health care market
(WorldNews Switzerland)

15. November 2018 Visit of the European First Line plant on Investor Day Several structural trends are sustaining growth in the global health care market. Depending on the subsegment and world region, annual growth for components for injectable drugs is over 10%. With its leading first line manufacturing standard and global presence, Datwyler is best positioned to capitalize on these growth opportunities. On the Investors` Day, investors, analysts and journalists will be given an insight into the First Line plant in Belgium. The previous annual targets for sales and EBIT margin are confirmed. The Datwyler Group is giving an in-depth insight into its growth strategy in the health care market...